Category Specific RSS

News

Jade Gas Holdings strikes deal with Mongolian Government to drill for gas

Mongolia has an abundance of coal deposits, making it the subject of significant exploration for coal bed mining, also known…

5 years ago

Alloggio makes attractive acquisition in Magnetic Island

Whoever named it Magnetic Island knew what was up. The pull of the equatorial paradise attracts over 290,000 people to…

5 years ago

Little Green Pharma to demerge its medicinal psychedelics business

There is an increasingly growing body of research globally into the use of psychedelic medicines to treat various health conditions.…

5 years ago

$13m in staff underpayment added to Star Entertainment’s long list of woes

If a global pandemic resulting in ongoing lockdowns, a regulatory investigation and corporate activity rejection were not enough to upset…

5 years ago

Luxury online retailer Cettire to jump on multi billion opportunity entering Chinese market

Despite living in track pants for the majority of the last few years, the retail fashion industry is very much…

5 years ago

Interest rates creating tense competition for the Big Four

After the Reserve Bank of Australia (RBA) announced that they were not increasing interest rates, banks are starting to feel…

5 years ago

REA sales surge on back of housing boom but flags upcoming headwinds

If the fear mongering headlines highlighting just how unreachable a first home is for millennials without outside assistance, the half…

5 years ago

Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test

Your Friday crash course: Diagnostic biomarkers are in essence, used to determine whether or not a patient has a medical…

5 years ago

Investors bullish on Amazon with price increase for Amazon Prime coming

Weeks after Netflix raised its subscription prices, Amazon (NASDAQ: AMZN) is set to jump on the bandwagon and bump up…

5 years ago

Pharmaxis reports progress in clinical trials despite COVID affecting industry

Things are well and truly on track for clinical stage pharmaceutical company Pharmaxis (ASX: PXS), a sentiment confirmed by CEO…

5 years ago